Greenspace Herbs Launches Quantum Ayurveda in U.S., Bringing Clinically Validated Botanicals to Wellness Consumers

Greenspace Herbs has officially launched its Quantum Ayurveda platform in the United States, supported by clinical research and a new operational base in New Jersey. The platform combines traditional Ayurvedic botanicals with frequency-based technological enhancement to deliver measurable effects at lower doses. Gregory Arabatzis has been appointed Chief Business Officer, USA, to oversee the U.S. expansion.

Quantum Ayurveda integrates traditional Ayurvedic ingredients with frequency-based technological enhancement, enabling more efficient absorption and measurable effects at reduced doses. Clinical studies published in peer-reviewed journals indicate that botanicals such as curcumin, ashwagandha, bacopa, and berberine can achieve results at approximately one-third of conventional doses, with accelerated response times.

Shafiulla Hirehal Nuruddin, Founder and Managing Director, Greenspace Herbs

"Today's wellness consumer is educated, demanding, and done with empty promises. They want to know: what does the science say, and will I feel the difference? Quantum Ayurveda was built specifically to answer both questions. We have done the clinical work. We have published the results. Now we are here in the U.S. to ensure that every consumer who chooses our platform experiences wellness that is real, measurable, and rooted in thousands of years of botanical knowledge — elevated by 21st-century science," said Shafiulla Hirehal Nuruddin, Founder & Managing Director, Greenspace Herbs.

The platform has already been launched in India and key Asian markets, with adoption among branded ingredient partners and finished-product collaborators. Greenspace Herbs is entering the U.S., a dietary supplement market valued at over $50 billion, with Gregory Arabatzis leading commercial operations. Arabatzis has over 20 years of experience in scaling nutraceutical brands and will focus on commercialization, education, and partnership development.

Gregory Arabatzis as Chief Business Officer, USA

"The U.S. market rewards clinically substantiated innovation. Quantum Ayurveda stands out because it is not theoretical — it is supported by published scientific data. Our focus now is structured commercialisation, education, and partnership development," said Gregory Arabatzis, Chief Business Officer – USA, Greenspace Herbs.

The U.S. launch highlights the platform’s attributes: clinically validated ingredients, effective lower-dose formulations, accelerated cellular response, and foundations in Ayurvedic knowledge enhanced by modern science. Greenspace Herbs also plans to establish Quantum Technology Frequency Labs in the U.S., intended for clinical collaborations, ingredient customization, and partner co-development programs.